The mean percentage of positive tumor cells for c-MET, RhoA, and CLDN18 expression was 16.2% (SD ± 24, mean H-score = 20.7 ± 36.8), 36.2% (SD ± 30), and 35.0% (SD ± 29.9), respectively. This evidence concerns the gene MET and neoplasm.